Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-22 5:21 pm Sale | 2021-09-20 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 16.400% | -1,109,644 (-13.78%) | Filing History |
| 2021-09-03 4:47 pm Sale | 2021-08-26 | 13D | Aadi Bioscience, Inc. AADI | ORBIMED ADVISORS LLC | 346,262 1.700% | -1 (-0.00%) | Filing |
| 2021-09-03 4:37 pm Sale | 2021-08-30 | 13D | BELLUS Health Inc. BLU | ORBIMED ADVISORS LLC | 2,954,800 3.800% | -1,000,000 (-25.29%) | Filing History |
| 2021-08-31 4:52 pm Purchase | 2021-08-23 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 6,881,953 7.700% | 1,071,428 (+18.44%) | Filing History |
| 2021-08-16 4:45 pm Unchanged | 2021-08-12 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 1,936,886 5.400% | 0 (Unchanged) | Filing History |
| 2021-08-12 4:17 pm Sale | 2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.600% | -254,721 (-10.32%) | Filing History |
| 2021-08-04 5:21 pm Unchanged | 2021-08-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 8,053,298 19.000% | 0 (Unchanged) | Filing History |
| 2021-07-14 5:08 pm Purchase | 2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 20.400% | 12,714,404 (New Position) | Filing History |
| 2021-07-13 9:24 pm Unchanged | 2021-07-11 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.400% | 0 (Unchanged) | Filing History |
| 2021-06-21 8:17 pm Purchase | 2021-06-15 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 3,042,764 7.300% | 3,042,764 (New Position) | Filing History |
| 2021-04-29 5:17 pm Purchase | 2021-04-26 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.800% | 4,012,281 (New Position) | Filing History |
| 2021-04-22 5:03 pm Purchase | 2021-04-20 | 13D | Synlogic, Inc. SYBX | ORBIMED ADVISORS LLC | 246,444 7.400% | 111,111 (+82.10%) | Filing History |
| 2021-04-20 4:37 pm Purchase | 2021-04-13 | 13G | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 4,830,004 13.800% | 4,830,004 (New Position) | Filing History |
| 2021-04-14 7:31 pm Purchase | 2021-03-30 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 1,936,886 6.560% | 1,936,886 (New Position) | Filing History |
| 2021-04-09 4:36 pm Purchase | 2021-04-06 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 72,873,494 84.000% | 70,422 (+0.10%) | Filing History |
| 2021-04-07 6:00 pm Purchase | 2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 13,679,055 27.800% | 13,679,055 (New Position) | Filing History |
| 2021-04-07 4:39 pm Sale | 2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX | ORBIMED ADVISORS LLC | 1,743,950 3.600% | -283,600 (-13.99%) | Filing History |
| 2021-03-29 4:25 pm Unchanged | 2021-03-25 | 13D | Synlogic, Inc. SYBX | ORBIMED ADVISORS LLC | 135,333 5.100% | 0 (Unchanged) | Filing History |
| 2021-03-26 5:07 pm Unchanged | 2021-03-25 | 13D | Graybug Vision, Inc. GRAY | ORBIMED ADVISORS LLC | 297,382 19.800% | 0 (Unchanged) | Filing History |
| 2021-03-25 4:15 pm Purchase | 2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR | ORBIMED ADVISORS LLC | 1,835,993 7.600% | 587,000 (+47.00%) | Filing History |